Office Hours : Monday to Saturday - 8am to 6pm
Invokana is an antidiabetic medication used in combination with exercise and diet for the treatment of Type 2 diabetes that is affecting an estimated 28 million Americans. It is prescribed to lower blood sugar and recover glycemic control in people suffering with serious disease Type 2 diabetes. It is a member of SGLT2 class of an antidiabetic medication that includes medications dapagliflozin (Farxiga) and empagloflozin (Jardiance). Invokana or canagliflozin is also available in combination with metformin and antidiabetic that is sold under the brand name of Invokamet.
Manufacturers and marketers present this medication in market to provide cure for Type 2 diabetes that if not treated properly increase the risk for various serious problems such as high blood pressure, nerve damage, heart disease, gastroparesis, blindness, foot complications, kidney failure, stroke and etc.
Invokana medication is manufactured and marketed by Janssen pharmaceuticals in the U.S. and developed by a Japanese pharmaceutical company, Mitsubishi Tanabe Pharma Corporation. Janssen pharmaceutical is a subsidiary of Johnson & Johnson (world’s largest pharmaceutical companies having the annual revenue of around $74 billion). It was a first SGLT2 scientifically known as type 2 sodium-glucose co-transporter) inhibitor that provide treatment for Type 2 diabetes by working differently as compared to other antidiabetics. It was hoped to help patients by lowering the level of blood sugar by causing kidneys to remove sugar through urine.
SGLT2 class of medications including Invokana starts providing treatment by preventing glucose from being reabsorbed back by the kidneys leading excess urine to excrete in the urine. The use of Invokana has result in the excretion of up-to 119 grams sugar being lost in the urine that is equivalent to 460 calories.
Invokana Lawsuits states that all those people who injured by Invokana can file lawsuits against manufacturers and marketers for not warning about increased risks of myocardial infarction (heart attacks), kidney failure and ketoacidosis cause while taking Invokana. According to Invokana lawsuits, it is believed that if manufacturer had properly warned about this then doctor and physicians would have prescribed a better medication other than Invokana for patients suffering with Type 2 diabetes and certainly patients would monitor their health on frequent basis for potential symptoms of renal impairment, high level of ketones and heart issues.
Injury or risk caused by Invokana antidiabetic medication may require hospitalization or long-term medical care. People who are injured by this drug can contact to Drugs Claim that works with dedicated and experienced team of lawyers who will file Invokana lawsuits against manufacturers and pharmacies of this drug and provide financial compensation. People whose loved one die due to medication injury can take assistance of Drugs Claim for wrongful-death compensation.